BRIEF published on 01/13/2026 at 01:05, 4 months 4 days ago CannaPharmaRX Reveals 2026 Growth Strategy amid Global Expansion Growth Strategy European Market CannapharmaRx Cannabis Export New Strains
PRESS RELEASE published on 01/13/2026 at 01:00, 4 months 4 days ago CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026 CannaPharmaRX provides an update on international export activities, new cannabis strains, 2026 plans, and regulatory status. Focus on expansion, quality, and profitability Cannabis Cultivation CannapharmaRx Strategic Plans Regulatory Update International Export
BRIEF published on 08/19/2025 at 20:35, 8 months 28 days ago CannaPharmaRX Expands Global Cannabis Exports Revenue Forecast International Markets Production Expansion CannapharmaRx Cannabis Exports
PRESS RELEASE published on 08/19/2025 at 20:30, 8 months 28 days ago CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue CannaPharmaRX strengthens global cannabis presence with strategic developments, major shipments to Europe, expanding presence in Israel, scaling up production, and strong Q3 revenue forecast Revenue Forecast Global Presence Cannabis CannapharmaRx Exports
BRIEF published on 05/06/2025 at 20:35, 1 year ago CannaPharmaRx Expands into European Market with German Shipment German Market Cannabis Cultivation International Shipment Canadian Growers THC Pricing
PRESS RELEASE published on 05/06/2025 at 20:30, 1 year ago CannapharmaRx Continues into New European Market with First Shipment Completed to Germany CannaPharmaRX, Inc. provides updates on successful cannabis shipments to Israel and Germany, plans for future shipments, and ongoing cultivation activities Cannabis Germany CannapharmaRx Shipments Cultivation
BRIEF published on 12/03/2024 at 17:50, 1 year 5 months ago CannaPharmaRX Advances with Alberta Facility and International Expansion International Expansion Revenue Projections CannapharmaRx Alberta Facility Branded Products
PRESS RELEASE published on 12/03/2024 at 17:45, 1 year 5 months ago CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy CannaPharmaRX, Inc. advances in cannabis production with new facility in Alberta, revenue projections, global exports, growth plans for 2025, new CEO search, and CTO engagement Revenue Projections CannapharmaRx Cannabis Production Global Exports New CEO Search
BRIEF published on 11/05/2024 at 19:25, 1 year 6 months ago CannaPharmaRx Advances with New Cannabis Shipment to Israel Revenue Growth International Expansion CannapharmaRx Cannabis Shipment Israel Market
PRESS RELEASE published on 11/05/2024 at 19:20, 1 year 6 months ago CannapharmaRx to Complete Additional Shipment in November CannaPharmaRX, Inc. reports continued progress at its cannabis facility in Cremona, Alberta. Recent shipments to Israel show growth potential. Expansion plans in Europe and globally Global Expansion Revenue Growth CannapharmaRx Cannabis Production Shipments To Israel
Published on 05/16/2026 at 01:15, 1 day 14 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 15 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 16 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 23 hours 21 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 19 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 21 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 1 day 21 hours ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 2 days ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/13/2026 at 17:45, 3 days 21 hours ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 3 days 21 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 3 days 21 hours ago Report on share repurchases from 6 to 12 May 2026
